MÖLNDAL, Sweden--(BUSINESS WIRE)--Regulatory News:
Arcam AB (STO:ARCM), listed on NASDAQ Stockholm, and leading supplier of Additive Manufacturing technology, announces that its powder subsidiary AP&C in Montreal, Canada, has put into service its third reactor, adding significant capacity to its titanium powder manufacturing operation.
AP&C, the high quality powder manufacturing subsidiary of Arcam, has completed the start-up of its third atomization reactor. AP&C uses proprietary technology for Plasma Atomization and designed and manufactured its third atomization reactor with a new state-of-the-art process control system. With this new investment, AP&C now has two production lines, encompassing reactors and related sieving and mixing equipment, fully dedicated to titanium products. A third reactor is dedicated to Inconel and other alloys. After the expansion AP&C has an atomization capacity of over 150 tons of titanium alloys per year.
“The need for high-end titanium powder is driven by the fast growth and adoption of Additive Manufacturing. Arcam is determined to serve the industry through cost efficient solutions thus converting traditional manufacturing into Additive Manufacturing. A requisite is to offer highest quality powder for production at competitive cost,” says Magnus René, CEO of Arcam.
“With this investment in capacity, we continue to drive AP&C’s mission to be the reference for high quality titanium and other high-melting point alloy powders for the Aerospace and Medical industries,” says Jacques Mallette, President of AP&C.
Arcam Group provides cost-efficient Additive Manufacturing solutions for production of metal components. Arcam’s Electron Beam Melting (EBM®) technology offers design freedom combined with excellent material properties and high productivity. Arcam is, through its solution orientation and comprehensive product offering, an innovative partner for advanced manufacturing, primarily for the aerospace and medical industries. Arcam offers EBM systems through Arcam AB in Sweden, powder metals through AP&C in Canada and implant contract manufacturing through DiSanto in the U.S. The company is listed on Nasdaq Stockholm and the Head Office is located in Mölndal, Sweden.
Arcam AB • Krokslätts Fabriker 27A • SE-431 37 Mölndal, Sweden • 46-31-710 32 00 • www.arcam.com
This information was brought to you by Cision http://news.cision.com